Sandoz GmbH Testimony at FDA Hearing on Biosimilars Will Emphasize Need for Consistent Regulatory Standards Across All Biologics
5/9/2012 10:46:44 AM
More...
|
Novartis AG Unit Recalling Prescription Eye Drops
7/21/2008 7:49:53 AM
More...
|
Altus Pharmaceuticals Inc. (ALTU) Secures Long-Term Growth Hormone Supply For ALTU-238 Clinical Development and Commercialization
7/10/2008 10:19:04 AM
More...
|
LifeCycle Pharma Announces Successful Completion of Pilot Studies on LCP-Feno and is Currently Preparing for Pivotal Studies
5/28/2008 10:26:43 AM
More...
|
FDA Warns Drugmakers Over Unapproved Headache Drugs, Companies Include: Novartis Pharma AG (NVS), Sandoz GmbH, IVAX Pharmaceuticals, Inc. (IVX), and Teva Pharmaceutical Industries Limited (TEVA)
3/2/2007 11:40:21 AM
More...
|
Barr Pharmaceuticals, Inc. (BRL) To Pay 22.5 Million USD To Settle Warfarin Law Suit With Novartis Corporation (NVS) Units
6/12/2006 10:56:39 AM
More...
|
340B Prime Vendor Program Adds Sandoz Pharmaceuticals To Growing List Of Companies Providing Low-Income Americans With Access To Antibiotic Injectibles And Oral Solid Medications
4/11/2006 12:09:28 PM
More...
|
FDA Rebuffs Novartis Pharma AG (NVS) Over Delay To Biogeneric Drug
11/15/2005 11:16:25 AM
More...
|
Novartis India Limited (NVS) To Sell Anti-TB Bulk Drug Business To Sandoz Private Limited
10/19/2005 5:13:04 PM
More...
|
Novartis India Limited (NVS) Plans To Sell Rifampicin Business To Sandoz
10/19/2005 5:12:34 PM
More...
|
|